image
Novavax, Inc. NVAX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 7.29
-7.42 %
$ 1.18 B
Market Cap
2.59
P/E
Price Target Average
215.50%
Revenue Forecast Estimate
--15.65%
EBIT Estimate
1.28%
Net Income Estimate
21.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Novavax, Inc.
image
Wall Street analysts predict an average 1-year price target for NVAX of $23 , with forecasts ranging from a low of $14 to a high of $31 .
NVAX Lowest Price Target Wall Street Target
14 USD 92.04%
NVAX Average Price Target Wall Street Target
23 USD 215.50%
NVAX Highest Price Target Wall Street Target
31 USD 325.24%
Price
Max Price Target
Min Price Target
Average Price Target
35353030252520201515101055Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart NVAX

image
$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart NVAX

image
$0.0$0.0($1.0b)($1.0b)($2.0b)($2.0b)($3.0b)($3.0b)($4.0b)($4.0b)($5.0b)($5.0b)($6.0b)($6.0b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart NVAX

image
$1.0b$1.0b$0.0$0.0($1.0b)($1.0b)($2.0b)($2.0b)($3.0b)($3.0b)($4.0b)($4.0b)($5.0b)($5.0b)($6.0b)($6.0b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029